Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A 24 Week Off Drug Extension, Parallel Group, Study Assessing Durability of Effect on Skeletal Muscle Strength and Function Following a 6-month Double-blind, Placebo Controlled Study Evaluating Bimagrumab in Older Adults With Sarcopenia (InvestiGAIT Extension)
Authors not listed
Novartis Pharmaceuticals · 2015
Abstract
This extension study was a 24-week off-drug follow-up of the core CBYM338E2202 (NCT ) study and the main objective was to determine the long-term durability of bimagrumab (BYM338) effect after a 6-month treatment period.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Anonymous. (2015). A 24 Week Off Drug Extension, Parallel Group, Study Assessing Durability of Effect on Skeletal Muscle Strength and Function Following a 6-month Double-blind, Placebo Controlled Study Evaluating Bimagrumab in Older Adults With Sarcopenia (InvestiGAIT Extension). <em>Novartis Pharmaceuticals</em>. https://clinicaltrials.gov/study/NCT02468674
Vancouver
Anonymous. A 24 Week Off Drug Extension, Parallel Group, Study Assessing Durability of Effect on Skeletal Muscle Strength and Function Following a 6-month Double-blind, Placebo Controlled Study Evaluating Bimagrumab in Older Adults With Sarcopenia (InvestiGAIT Extension). Novartis Pharmaceuticals. 2015.
BibTeX
@misc{anon2015AWeekO,
title = {A 24 Week Off Drug Extension, Parallel Group, Study Assessing Durability of Effect on Skeletal Muscle Strength and Function Following a 6-month Double-blind, Placebo Controlled Study Evaluating Bimagrumab in Older Adults With Sarcopenia (InvestiGAIT Extension)},
author = {Anonymous},
journal = {Novartis Pharmaceuticals},
year = {2015},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Novartis Pharmaceuticals 2014
Open access · US-GOV
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
University of Virginia 2003
Open access · US-GOV
Effect of Fasting on Ghrelin and Growth Hormone in Healthy Young and Older Adults
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace 2021
Open access · US-GOV
Evaluation of a Screening Strategy for Sarcopenia: a Monocentric Prospective Cohort Study
Rocky Mountain Retina Consultants 2006
Open access · US-GOV
Lucentis in the Treatment of Macular Edema - A Phase II, Single Center, Randomized Study to Evaluate the Efficacy of Ranibizumab Versus Focal Laser Treatment in Subjects With Diabetic Macular Edema
Osteoporosis International 2013
Citation only
Frailty and osteoporosis in older women—a prospective study
Pfizer 2009
Open access · US-GOV